Global Cannabis
Stock Index
Since 2013 the Global Cannabis Stock Index has represented the overall publicly-traded market for the medical and legal marijuana sector.
NCV provided updates to the index, but the daily changes are no longer shared publicly.
As of the close on 04/30, SMG was removed, leaving 23 members. The index ceased to be calculated as of 05/15/26.
The 24 stocks that were in the index as of the close on 03/31 included:
| ACB |
| AFCG |
| CGC |
| CRLBF |
| CRON |
| CURLF |
| CWBHF |
| GLASF |
| GTBIF |
| HITI |
| IIPR |
| JAZZ |
| LIEN |
| MAPS |
| NLCP |
| OGI |
| REFI |
| SMG |
| SNDL |
| TCNNF |
| TLRY |
| TPB |
| VFF |
| VRNO |
The Global Cannabis Stock Index, which is dollar-denominated and based upon the prices of the U.S. listing for each member, is rebalanced quarterly, with each member weighted equally at that time.
For the 03/31/26 rebalancing, each stock was required to have an average daily trading value in excess of $0.5 million and a minimum price of at least $0.50 (10-day average) as of 03/24/26. Non-U.S. companies must have a U.S. listing in order to be included. The dollar-volume threshold for non-U.S. companies includes both U.S. and non-U.S. volume, but there is an additional requirement that the daily average U.S. dollar-volume be in excess of $400K.
Inclusion in any index is not an endorsement or recommendation of any company. This Site is not an intermediary, broker/dealer, investment advisor, or exchange and does not provide investment advice or investment advisory services.
For cannabis index licensing inquiries, please contact us.
Visit and bookmark the data-driven, fact-based Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures.